(Q40495779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Preferential targeting of vesicular stomatitis virus to breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Patricia Whitaker-Dowling

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Yanhua Gao

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Judith A Griffin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

21 September 2017

330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

24-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527831%20AND%20SRC:MED&resulttype=core&format=json

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Vesicular stomatitis virus expressing a chimeric Sindbis glycoprotein containing an Fc antibody binding domain targets to Her2/neu overexpressing breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

An oncolytic measles virus engineered to enter cells through the CD20 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Targeted retroviral infection of tumor cells by receptor cooperation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Antibody-directed targeting of retroviral vectors via cell surface antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

The surface conformation of Sindbis virus glycoproteins E1 and E2 at neutral and low pH, as determined by mass spectrometry-based mapping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Cytolytic viruses as potential anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Superinfection exclusion by vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Oncolytic viruses as therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Placement of the structural proteins in Sindbis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Cancer gene and oncolytic virus therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048

Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.048